Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Richard E. Champlin

piggyBacTransposon/Transposase System to Generate CD19-Specific T Cells for the Treatment of B-Lineage Malignancies

Human Gene Therapy

English

Randomized Phase II Trial Comparing Two Dose Levels of Thymoglobulin in Patients Undergoing Unrelated Donor Hematopoietic Cell Transplant

Leukemia and Lymphoma

English

The Effect of Peritransplant Minimal Residual Disease in Adults With Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Lymphoma, Myeloma and Leukemia

English

Outcomes in Patients With Relapsed or Refractory Acute Promyelocytic Leukemia Treated With or Without Autologous or Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Lymphoma, Myeloma and Leukemia

English

Feasibility of Allografting in Patients With Advanced Acute Lymphoblastic Leukemia After Salvage Therapy With Inotuzumab Ozogamicin

Clinical Lymphoma, Myeloma and Leukemia

English

Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation

Clinical Lymphoma, Myeloma and Leukemia

English

5-Aza-2′-Deoxycytidine Sensitizes Busulfan-Resistant Myeloid Leukemia Cells by Regulating Expression of Genes Involved in Cell Cycle Checkpoint and Apoptosis

English

Functional Assessment and Specific Depletion of Alloreactive Human T Cells Using Flow Cytometry

English

Rapid Induction of Complete Donor Chimerism by the Use of a Reduced-Intensity Conditioning Regimen Composed of Fludarabine and Melphalan in Allogeneic Stem Cell Transplantation for Metastatic Solid Tumors

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Richard E. Champlin

piggyBacTransposon/Transposase System to Generate CD19-Specific T Cells for the Treatment of B-Lineage Malignancies

Randomized Phase II Trial Comparing Two Dose Levels of Thymoglobulin in Patients Undergoing Unrelated Donor Hematopoietic Cell Transplant

The Effect of Peritransplant Minimal Residual Disease in Adults With Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Outcomes in Patients With Relapsed or Refractory Acute Promyelocytic Leukemia Treated With or Without Autologous or Allogeneic Hematopoietic Stem Cell Transplantation

Feasibility of Allografting in Patients With Advanced Acute Lymphoblastic Leukemia After Salvage Therapy With Inotuzumab Ozogamicin

Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation

5-Aza-2′-Deoxycytidine Sensitizes Busulfan-Resistant Myeloid Leukemia Cells by Regulating Expression of Genes Involved in Cell Cycle Checkpoint and Apoptosis

Functional Assessment and Specific Depletion of Alloreactive Human T Cells Using Flow Cytometry

Rapid Induction of Complete Donor Chimerism by the Use of a Reduced-Intensity Conditioning Regimen Composed of Fludarabine and Melphalan in Allogeneic Stem Cell Transplantation for Metastatic Solid Tumors